61
New Ray Medicine International Holding Ltd.
6108.HK · HKSE
$0.23 -2.17% (-$0.01)
1M +5.02%
Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
50 /100
Moderate Beta -3.92x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 6108.HK
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Qiuqin Wang
Employees
31
Headquarters
Hangzhou